27th Feb 2024 A plain language summary looking at nivolumab that is given after stage 2B/2C melanoma is removed by surgery
12th Apr 2023 Plain Language Summary: the CheckMate 274 study, treatment of muscle-invasive urothelial cancer with nivolumab